摘要
目的分析消化性溃疡联合康复新液结合PPI(质子泵抑制剂)三联治疗的临床疗效。方法在本院2013年12月至2017年9月收治的消化性溃疡患者中选取78例,随机分为两组,对照组单独采用PPI三联疗法治疗,观察组在对照组基础上加用康复新液治疗,对比两组临床疗效、Hp转阴率与不良反应发生情况。结果观察组治疗总有效率为94.87%,高于对照组74.36%,Hp阴性患者有37例,阴性率为94.87%,明显高于对照组64.10%,差异具有统计学意义(P<0.05);观察组不良反应发生率为7.69%;对照组5.13%;两组并发症发生率比较差异无统计学意义(c2=0.213 7,P=0.642 9)。结论消化性溃疡联合康复新液结合PPI三联治疗的临床疗效显著,且安全性高,可将其广泛推广。
Objective To analyze the clinical efficacy of peptic ulcer combined with rehabilitation new fluid combined with PPI triple therapy.Methods From December 2013 to September 2017, 78 patients with peptic ulcer admitted to our hospital were randomly divided into two groups.The control group was treated with PPI triple therapy alone. The observation group was treated with Rehabilitation new fluid on the basis of the control group, and the clinical efficacy, Hp negative conversion rate and adverse reactions of the two groups were compared. Results The total effective rate of the observation group was 94.87%, which was higher than that of the control group 74.36%, and 37 cases of Hp-negative patients, the negative rate was 94.87%, which was significantly higher than that of the control group(64.10%). The difference was significant(P<0.05);the incidence of adverse reactions was 7.69% in the observation group and 5.13% in the control group. There was no significant difference in the incidence of complications between the two groups. Conclusion The clinical efficacy of peptic ulcer combined with rehabilitation new fluid combined with PPI triple therapy is significant and safe, which can be widely promoted.
作者
张翔
Zhang Xiang(Leping people' s hospital, Leping, Jiangxi, 333300, China)
出处
《当代医学》
2019年第14期81-82,共2页
Contemporary Medicine
关键词
消化性溃疡
康复新液
PPI三联治疗
联合治疗
奥美拉唑
Peptic ulcer
Rehabilitation new fluid
PPI triple therapy
Combination therapy
Omeprazole
